Cargando…

Blocking myostatin: muscle mass equals muscle strength?

Detalles Bibliográficos
Autores principales:	Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749583/ https://www.ncbi.nlm.nih.gov/pubmed/33340286 http://dx.doi.org/10.1002/jcsm.12647

Ejemplares similares

The role of myostatin in muscle wasting: an overview
por: Elkina, Yulia, et al.
Publicado: (2011)

The 10th year of the Journal of Cachexia, Sarcopenia and Muscle
por: Anker, Markus S., et al.
Publicado: (2020)

Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018
por: von Haehling, Stephan, et al.
Publicado: (2018)

Moving on up: the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2015)

The Journal of Cachexia, Sarcopenia and Muscle stays the front‐runner in geriatrics and gerontology
por: Anker, Markus S., et al.
Publicado: (2019)

The Journal of Cachexia, Sarcopenia and Muscle in 2019
por: von Haehling, Stephan, et al.
Publicado: (2019)

Moving upwards – the journal of cachexia, sarcopenia and muscle in 2016
por: von Haehling, Stephan, et al.
Publicado: (2016)

Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017
por: von Haehling, Stephan, et al.
Publicado: (2017)

Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention
por: Anker, Stefan D., et al.
Publicado: (2014)

More colour to the Journal: new style, new publisher, but still Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2015)

From muscle wasting to sarcopenia and myopenia: update 2012
por: von Haehling, Stephan, et al.
Publicado: (2012)

Are we closer to having drugs to treat muscle wasting disease?
por: Morley, John E., et al.
Publicado: (2014)

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
por: von Haehling, Stephan, et al.
Publicado: (2021)

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
por: Pötsch, Mareike S., et al.
Publicado: (2013)

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2010)

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
por: von Haehling, Stephan, et al.
Publicado: (2015)

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019
por: von Haehling, Stephan, et al.
Publicado: (2019)

Muscle wasting: an overview of recent developments in basic research
por: Palus, Sandra, et al.
Publicado: (2014)

Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire
por: Prado, Carla M., et al.
Publicado: (2020)

More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live
por: Anker, Stefan D., et al.
Publicado: (2018)

Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength
por: Smith, Rosamund C., et al.
Publicado: (2020)

Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016)

Nutrition in cachexia: from bench to bedside
por: Konishi, Masaaki, et al.
Publicado: (2016)

Myostatin/Appendicular Skeletal Muscle Mass (ASM) Ratio, Not Myostatin, Is Associated with Low Handgrip Strength in Community-Dwelling Older Women
por: Choi, Soo Jeong, et al.
Publicado: (2021)

Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature
por: von Haehling, Stephan
Publicado: (2018)

Novel myostatin-specific antibody enhances muscle strength in muscle disease models
por: Muramatsu, Hiroyasu, et al.
Publicado: (2021)

Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
por: von Haehling, Stephan, et al.
Publicado: (2016)

Muscle wasting disease: a proposal for a new disease classification
por: Anker, Stefan D., et al.
Publicado: (2014)

Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies
por: da Fonseca, Guilherme Wesley Peixoto, et al.
Publicado: (2020)

Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
por: Scherbakov, Nadja, et al.
Publicado: (2022)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)
por: Scherbakov, Nadja, et al.
Publicado: (2016)

Heart failure epidemiology and novel treatments in Japan: facts and numbers
por: Konishi, Masaaki, et al.
Publicado: (2016)

Identification of Molecules from Coffee Silverskin That Suppresses Myostatin Activity and Improves Muscle Mass and Strength in Mice
por: Kim, Jeong Han, et al.
Publicado: (2021)

Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
por: Pirruccello-Straub, M., et al.
Publicado: (2018)

SAT670 Is Myostatin A Biomarker Of Skeletal Muscle Mass?
por: Orioli, Laura, et al.
Publicado: (2023)

Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007)

ESC Heart Failure increases its impact factor
por: Anker, Markus S., et al.
Publicado: (2020)

Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects
por: Planella-Farrugia, Cristina, et al.
Publicado: (2019)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science
por: Lena, Alessia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7sqrv0oa2i1kvdr3gt9dd7iufu